Thermo Fisher center forms partnerships for biomarkers

By The Science Advisory Board staff writers

September 14, 2020 -- Thermo Fisher Scientific announced new collaborations for clinical biomarker discovery among the Thermo Fisher Precision Medicine Science Center, AstraZeneca, and the University of Nebraska Medical Center.

The alliances strengthen the center's mission of creating standardized workflows with pharma and academic partners to streamline the transition from biomarker research to clinical implementation.

Through the collaborations, ongoing and planned studies with both groups will utilize standardized plasma protein profiling workflows, including Thermo Fisher's ultrahigh-throughput plasma protein profiling workflow for biomarker discovery, for a range of conditions. Other standardized workflows consist of automated sample preparation for untargeted and targeted methods in combination with Thermo's Orbitrap Exploris 480 and Exploris 240 mass spectrometers.

Using advanced sample processing and downstream analytical applications, the collaboration with AstraZeneca aims to establish a model for clinical proteomics to help identify new drug targets and biomarkers.

Researchers at the University of Nebraska Medical Center are interested in filling research gaps between sample analysis and clinical applications.

Thermo Fisher opens new bioprocessing collaboration center
Thermo Fisher Scientific has opened a new bioprocessing collaboration center in St. Louis to accelerate innovations in biologics manufacturing.
Thermo Fisher to manufacture Inovio's COVID-19 vaccine
Thermo Fisher Scientific has signed a letter of intent to manufacture Inovio's DNA COVID-19 vaccine candidate, INO-4800.
Thermo Fisher opens manufacturing site for COVID-19 viral transport media
Thermo Fisher Scientific has opened its new $40 million facility in Lenexa, KS, dedicated to viral transport media production. The groundbreaking...
Thermo Fisher debuts hematology/oncology assays
Thermo Fisher Scientific has debuted hematology/oncology assays that enable simultaneous analysis of DNA mutations and RNA fusion transcripts in myeloid...
Thermo releases spectrometry products for proteomics
Thermo Fisher Scientific has announced an exclusive license agreement with software firm MSAID for intelligent software that uses deep learning facilitated...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter